Prelude Fertility

Forta Announces $55 Million Series A To Build AI Healthcare and Improve Access To Quality Care

Retrieved on:

Wednesday, January 17, 2024

Entrepreneurship, Conditional sentence, ASD, Insight Partners, Patient, Research, Spectrum, Alzheimer's disease, SAN, Insight, State government, Caregiver, ABA, Prelude Fertility, Empathy, Physician, Education, LLM

SAN FRANCISCO, Jan. 17, 2024 /PRNewswire/ -- Forta, an AI healthcare company improving access to dependable quality care, today announced it has raised $55 million in Series A financing led by global software investor Insight Partners. Leading technology and healthcare investors participated in the round, including Exor Ventures and Alumni Ventures, as well as founders of 23&Me, Curative, Forward, Flexport, Warby Parker, Prelude Fertility, Harry's and Allbirds. With this new funding, Forta will expand its family-powered autism therapy practice to provide AI-enabled applied behavior analysis (ABA) therapy and develop its suite of clinical algorithms.

Key Points:

Forta is expanding access to dependable, quality care starting with autism therapy
SAN FRANCISCO, Jan. 17, 2024 /PRNewswire/ -- Forta , an AI healthcare company improving access to dependable quality care, today announced it has raised $55 million in Series A financing led by global software investor Insight Partners.
Wait times to receive care are increasing as more individuals are diagnosed with conditions like autism , Alzheimer's , and chronic diseases .
Forta is answering their call with its mission to enable access to high-quality healthcare by researching and deploying the latest advances in AI, including large language models (LLMs), to empower caregivers and improve clinical care.
"Our current healthcare system is not able to provide dependable and quality care to families when they need it.

Dresner Partners Advised Conceptions Reproductive Associates of Colorado on Its Partnership With IVIRMA Global

Retrieved on:

Wednesday, August 23, 2023

CHICAGO, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Dresner Partners, an award-winning, FINRA-registered, middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it advised Conceptions Reproductive Associates of Colorado (Conceptions), on its partnership with IVIRMA Global.

Key Points:

CHICAGO, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Dresner Partners, an award-winning, FINRA-registered, middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it advised Conceptions Reproductive Associates of Colorado (Conceptions), on its partnership with IVIRMA Global.
Founded in 1986, Conceptions operates a fertility center with four office locations throughout Colorado, combining cutting-edge innovation, outstanding medical expertise, and individualized care.
Conceptions has a leading reputation for clinical excellence and will be a great addition to IVIRMA Global.
Steven M. Dresner, President of Dresner Partners added, “Conceptions benefits from an excellent partner to support its next phase of development.

Dresner Partners Advised the Advanced IVF Institute on Its Sale to CCRM Fertility

Retrieved on:

Tuesday, August 1, 2023

CHICAGO, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Dresner Partners, an award-winning, FINRA-registered middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it advised The Advanced IVF Institute on its sale to CCRM Fertility, a global pioneer in fertility treatment, research and science.

Key Points:

CHICAGO, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Dresner Partners, an award-winning, FINRA-registered middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it advised The Advanced IVF Institute on its sale to CCRM Fertility, a global pioneer in fertility treatment, research and science.
Founded by Dr. William Schoolcraft more than 35 years ago, CCRM Fertility specializes in the most advanced fertility treatments, with deep expertise in IVF, fertility testing, egg freezing, PGT, third party reproduction and egg donation.
The Advanced IVF Institute and CCRM Fertility share a strong commitment to delivering first-class reproductive services to patients and I’m excited about the long-term potential of our new partnership.”
Mitchell Stern, Managing Director and Head of the Healthcare Group at Dresner Partners said, “We enjoyed working closely with Dr. Miller and the rest of The Advanced IVF Institute team.
There continues to be a tremendous opportunity for providers to combine their resources to meet their long-term growth objectives.”
Dresner Partners is the leading provider of investment banking services to the fertility (IVF) sector, having closed numerous transactions including the sale of IGENOMIX, the merger of RMANJ and IVI of Spain, the sale of Advanced Fertility of Chicago to Prelude Fertility, the sale of Santa Monica Fertility to Webster Equity Partners, the sale of In Via Fertility to InVitro Sciences (now First Fertility), the sale of Institute for Human Reproduction to Pinnacle Fertility, the sale of Dominion Fertility to Pinnacle Fertility, the sale of Center of Reproductive Medicine to US Fertility, the sale of IVF1 to Pinnacle Fertility, the sale of Fertility Institute of New Jersey & New York to Axia Women’s Health, and the sale of RADfertility to CCRM Fertility.

Dresner Partners Advised RADfertility in Its Sale to CCRM Fertility

Retrieved on:

Tuesday, December 6, 2022

CHICAGO, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Dresner Partners, a leading FINRA-registered, middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it advised RADfertility in its sale to CCRM Fertility.

Key Points:

CHICAGO, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Dresner Partners, a leading FINRA-registered, middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it advised RADfertility in its sale to CCRM Fertility.
CCRM Fertility is a global pioneer in fertility treatment, research and science.
The synergies between the two organizations will further enhance and expand the reach of the CCRM network.”
Steven M. Dresner, President of Dresner Partners added, “We are very pleased that we were able to help RADfertility find a strategic partner in CCRM Fertility.
There is tremendous opportunity for providers to combine their resources to meet their long-term growth objectives.”
Dresner Partners is a leading provider of investment banking services to the fertility (IVF) sector, having closed numerous transactions including the sale of IGENOMIX, the merger of RMA NJ and IVI of Spain, the sale of Advanced Fertility of Chicago to Prelude Fertility, the sale of Santa Monica Fertility to Webster Equity Partners, the sale of In Via Fertility to InVitro Sciences (now First Fertility), the sale of Institute for Human Reproduction to Pinnacle Fertility, the sale of Dominion Fertility to Pinnacle Fertility, the sale of Center of Reproductive Medicine to US Fertility, the sale of IVF1 to Pinnacle Fertility, the sale of Fertility Institute of New Jersey & New York to Axia Women’s Health, and the sale of RADfertility to CCRM Fertility.

Dresner Partners Advised Fertility Institute of NJ & NY in Its Sale to Axia Women’s Health

Retrieved on:

Tuesday, September 6, 2022

CHICAGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Dresner Partners, a leading FINRA-registered, middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it advised Fertility Institute of New Jersey & New York in its sale to Axia Womens Health.

Key Points:

CHICAGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Dresner Partners, a leading FINRA-registered, middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it advised Fertility Institute of New Jersey & New York in its sale to Axia Womens Health.
The Institute prides itself on using the most advanced scientific knowledge to provide personalized and affordable fertility care, helping patients maximize fertility potential and become parents.
Mitchell Stern, Managing Director and Head of the Healthcare Group at Dresner Partners, said, We are very pleased that Fertility Institute of New Jersey & New York and Axia Womens Health completed this transaction.
Fertility Institute of New Jersey & New York, combined with Axias 200 womens health centers, is poised to rapidly accelerate its growth.

Dresner Partners Advised IVF1 in Its Sale to Pinnacle Fertility

Retrieved on:

Tuesday, July 26, 2022

CHICAGO, July 26, 2022 (GLOBE NEWSWIRE) -- Dresner Partners, a leading FINRA-registered, middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it advised IVF1 in its sale to Pinnacle Fertility.

Key Points:

CHICAGO, July 26, 2022 (GLOBE NEWSWIRE) -- Dresner Partners, a leading FINRA-registered, middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it advised IVF1 in its sale to Pinnacle Fertility.
Pinnacle Fertility was founded in 2021 and is one of the nations fastest-growing physician-centric fertility care platforms, supporting more than 25 high-performing fertility clinics and comprehensive fertility service providers nationwide.
Andrew Mintz, CEO of Pinnacle Fertility said, We are thrilled to have Dr. Morris and the entire IVF1 team join the Pinnacle family.
Dresner Partners is a leading provider of investment banking services to the fertility (IVF) sector, having closed numerous transactions including the sale of IGENOMIX, the merger of RMA of N.J. and IVI of Spain, the sale of Advanced Fertility of Chicago to Prelude Fertility, the sale of Santa Monica Fertility to Webster Equity Partners, the sale of In Via Fertility to InVitro Sciences (now First Fertility), the sale of Institute for Human Reproduction to Webster Equity Partners, the sale of Dominion Fertility to Webster Equity Partners, the sale of Center of Reproductive Medicine to US Fertility, and the sale of IVF1 to Pinnacle Fertility.

Fertilitas Ventures, MKH Capital Partners' Fertility Platform, Announces the Hiring of Four Key Executives

Retrieved on:

Wednesday, July 13, 2022

MIAMI, July 13, 2022 /PRNewswire/ -- Fertilitas Ventures ("Fertilitas"), a fertility practice management services organization backed by MKH Capital Partners, announced the hiring of its executive team and independent board members.

Key Points:

MIAMI, July 13, 2022 /PRNewswire/ -- Fertilitas Ventures ("Fertilitas"), a fertility practice management services organization backed by MKH Capital Partners, announced the hiring of its executive team and independent board members.
Prior to working in the fertility industry, Rick spent 10+ years in healthcare leadership roles at Southeastern Healthcare, Amerifit Brands, and SportPharma Nutritionals.
MKH has previously announced the launch of its fertility practice management services organization, which has been renamed Fertilitas Ventures.
MKH offers a strong combination of long-term family capital and large-scale private equity expertise and resources.

Aspire Fertility San Antonio Welcomes Jennifer Knudtson, MD to its Team of Renowned Fertility Specialists

Retrieved on:

Thursday, May 13, 2021

Fertility medicine, Reproduction, Human reproduction, Medical specialties, Human pregnancy, Obstetrics, Egg donation, Fertility, In vitro fertilisation, Oocyte cryopreservation, Surrogacy, Prelude Fertility

b'SAN ANTONIO, May 13, 2021 /PRNewswire/ -- Aspire Fertility San Antonio , the area\'s leading fertility provider committed to helping patients build their families and is part of The Prelude Network , announces today the addition of Jennifer Knudtson, MD to its practice.

Key Points:

b'SAN ANTONIO, May 13, 2021 /PRNewswire/ -- Aspire Fertility San Antonio , the area\'s leading fertility provider committed to helping patients build their families and is part of The Prelude Network , announces today the addition of Jennifer Knudtson, MD to its practice.
In response to a growing demand for top-quality reproductive services and specialists due in part to San Antonio\'s surge in residential growth, the practice opened a new clinic in Stone Oak in late 2020.
With locations in Atlanta, Austin, Dallas, Houston, McAllen and San Antonio metropolitan areas, the Aspire family of clinics provides five-star fertility care to patients, led by industry experts who are on the leading edge of reproductive medicine.
They offer a full spectrum of comprehensive female and male fertility care, including IVF, egg freezing, genetic screening (PGD/PGS), egg donation, surrogacy and LGBTQ+ fertility.\n'

CCRM Fertility's 2021 State of Fertility Survey Finds Nearly 46% of Dallas-Fort Worth Residents are Uneducated on Fertility Health

Retrieved on:

Tuesday, March 16, 2021

Fertility medicine, Articles, Reproduction, Human reproduction, Fertility preservation, In vitro fertilisation, Assisted reproductive technology, Egg donation, Fertility, Prelude Fertility

Local Dallas residents Sherry and Tony Smith can attest to the importance of taking charge of your fertility health.

Key Points:

Local Dallas residents Sherry and Tony Smith can attest to the importance of taking charge of your fertility health.
In Sherry's early adulthood she found an ovarian tumor, which prompted her to take her fertility health into her own hands.
Additional findings from the survey include:
For more information about CCRM Fertility Dallas-Fort Worth or to inquire about fertility treatment options, please visit www.ccrmivf.com/dallasfortworth .
CCRM Fertility specializes in the most advanced fertility treatments, with deep expertise in in vitro fertilization (IVF), fertility assessment, fertility preservation, genetic testing, third party reproduction and egg donation.

CCRM Fertility's 2021 State of Fertility Survey Finds Nearly 40% of San Francisco Bay Area Residents Struggle with Infertility

Retrieved on:

Tuesday, March 9, 2021

Fertility medicine, Articles, Reproduction, Human reproduction, In vitro fertilisation, Fertility preservation, Assisted reproductive technology, Fertility, Egg donation, Prelude Fertility

SAN FRANCISCO, March 9, 2021 /PRNewswire/ -- CCRM Fertility , a global pioneer in fertility science, research and treatment, announced the results of its 2021 State of Fertility survey in San Francisco.

Key Points:

SAN FRANCISCO, March 9, 2021 /PRNewswire/ -- CCRM Fertility , a global pioneer in fertility science, research and treatment, announced the results of its 2021 State of Fertility survey in San Francisco.
After undergoing an IVF cycle at CCRM Fertility San Francisco, they now have a beautiful baby girl.
For more information about CCRM Fertility San Francisco or to inquire about fertility treatment options, please visit https://www.ccrmivf.com/sanfrancisco/ .
CCRM Fertility specializes in the most advanced fertility treatments, with deep expertise in in vitro fertilization (IVF), fertility assessment, fertility preservation, genetic testing, third party reproduction and egg donation.